Literature DB >> 18439063

Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy.

Mohd Fahad Ullah1.   

Abstract

Multidrug resistance (MDR) continues to be a major challenge to effective chemotherapeutic interventions against cancer. Various types of cancers have been observed to exhibit this phenomenon, a strategy that involves cellular and non cellular mechanisms employed by cancer cells to survive the cytotoxic actions of various structurally and functionally unrelated drugs. The present article is a brief review of the fundamental mechanisms underlying the phenomenon of MDR in cancer cells and some novel approaches addressed at its inhibition, circumvention or reversal. The emergence of natural products as potential anti-MDR molecules is of particular significance. Since many of these are essential components of the human diet, they are expected to possess fewer side effects and may possibly represent a new generation of MDR modulators.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439063

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  48 in total

1.  Synthesis of novel 4-Boc-piperidone chalcones and evaluation of their cytotoxic activity against highly-metastatic cancer cells.

Authors:  Carlimar Ocasio-Malavé; Metsiel J Donate; María M Sánchez; Jesús M Sosa-Rivera; Joseph W Mooney; Tomás A Pereles-De León; Néstor M Carballeira; Beatriz Zayas; Christian E Vélez-Gerena; Magaly Martínez-Ferrer; David J Sanabria-Ríos
Journal:  Bioorg Med Chem Lett       Date:  2019-10-28       Impact factor: 2.823

2.  Establishment and characterization of a triple negative basal-like breast cancer cell line with multi-drug resistance.

Authors:  Sergei Boichuk; Aigul Galembikova; Alexandr Sitenkov; Ramil Khusnutdinov; Pavel Dunaev; Elena Valeeva; Natalia Usolova
Journal:  Oncol Lett       Date:  2017-08-23       Impact factor: 2.967

3.  The novel gene HA117 promotes in vitro and in vivo drug resistance in mouse colon tumor cells.

Authors:  Y X Guo; Y H Xu; G H Zheng; X Q Jin
Journal:  Cancer Gene Ther       Date:  2017-07-21       Impact factor: 5.987

4.  Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone.

Authors:  Qing Chen; Jie Zhou; Chunfang Jiang; Juan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-06-17

5.  The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy.

Authors:  Olga A Patutina; Nadezda L Mironova; Nelly A Popova; Vasily I Kaledin; Valery P Nikolin; Valentin V Vlassov; Marina A Zenkova
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

6.  Semantic similarity for automatic classification of chemical compounds.

Authors:  João D Ferreira; Francisco M Couto
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

7.  Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line.

Authors:  Gennifer D Goode; Billy R Ballard; H Charles Manning; Michael L Freeman; Yibin Kang; Sakina E Eltom
Journal:  Int J Cancer       Date:  2013-07-05       Impact factor: 7.396

Review 8.  A short update on cancer chemoresistance.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Wien Med Wochenschr       Date:  2014-09-24

Review 9.  An insight into the therapeutic potential of quinazoline derivatives as anticancer agents.

Authors:  Irshad Ahmad
Journal:  Medchemcomm       Date:  2017-04-07       Impact factor: 3.597

10.  The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer.

Authors:  Wen-Qing Hu; Chun-Wei Peng; Yan Li
Journal:  J Exp Clin Cancer Res       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.